1. Home
  2. NEO vs KYN Comparison

NEO vs KYN Comparison

Compare NEO & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

SELL

Current Price

$16.54

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Logo Kayne Anderson Energy Infrastructure Fund Inc.

KYN

Kayne Anderson Energy Infrastructure Fund Inc.

SELL

Current Price

$14.10

Market Cap

2.4B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NEO
KYN
Founded
2001
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
NEO
KYN
Price
$16.54
$14.10
Analyst Decision
Buy
Analyst Count
12
0
Target Price
★ $21.85
N/A
AVG Volume (30 Days)
★ 2.3M
287.7K
Earning Date
10-28-2026
01-01-0001
Dividend Yield
N/A
★ 8.99%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$10.71
N/A
Revenue Next Year
$9.96
N/A
P/E Ratio
★ N/A
$20.75
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$11.31
52 Week High
$20.15
$15.17

Technical Indicators

Market Signals
Indicator
NEO
KYN
Relative Strength Index (RSI) 43.04 46.46
Support Level $15.57 $14.01
Resistance Level $16.92 $14.35
Average True Range (ATR) 0.98 0.23
MACD -0.18 0.03
Stochastic Oscillator 23.00 66.11

Price Performance

Historical Comparison
NEO
KYN

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

Share on Social Networks: